Further mechanisms of PI3K pathway hyperactivation include phosphatase and tensin homolog (PTEN) loss of function (30 % of breast cancers), activation of receptor tyrosine kinases (RTK), and the amplification or mutation of AKT [7]. This evidence concerns the gene PIK3CD and breast carcinoma.